COFLEX® INTERLAMINAR TECHNOLOGY

Prosthesis, Spinous Process Spacer/plate

FDA Premarket Approval P110008

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the coflex interlaminar technology. This device is indicated for use in one- or two-level lumbar stenosis from l1- l5 in skeletally mature patients with at least moderate impairment in function, who experience relief in flexion from their symptoms of leg/buttocks/ groin pain, with or without back pain, and who have undergone at least 6 month of non-operative treatment. The coflex is intended to be implanted midline between adjacent lamina of 1 or 2 contiguous lumbar motion segments. Interlaminar stabilization is performed after decompression of stenosis at the affected level(s).

DeviceCOFLEX® INTERLAMINAR TECHNOLOGY
Classification NameProsthesis, Spinous Process Spacer/plate
Generic NameProsthesis, Spinous Process Spacer/plate
ApplicantPARADIGM SPINE, LLC
Date Received2011-03-03
Decision Date2012-10-17
Notice Date2012-11-08
PMAP110008
SupplementS
Product CodeNQO
Docket Number12M-1085
Advisory CommitteeOrthopedic
Expedited ReviewNo
Combination Product No
Applicant Address PARADIGM SPINE, LLC 505 Park Avenue, 14th Floor new York, NY 10022
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P110008Original Filing
S013 2021-01-06 Normal 180 Day Track No User Fee
S012 2020-07-09 Special (immediate Track)
S011 2019-10-29 Normal 180 Day Track No User Fee
S010 2017-08-17 Normal 180 Day Track No User Fee
S009 2017-07-03 Normal 180 Day Track No User Fee
S008 2017-06-26 Normal 180 Day Track
S007 2016-10-18 Normal 180 Day Track No User Fee
S006 2016-09-01 Real-time Process
S005 2016-03-09 Normal 180 Day Track No User Fee
S004 2016-01-14 30-day Notice
S003 2014-02-19 Normal 180 Day Track No User Fee
S002 2012-11-26 Normal 180 Day Track No User Fee
S001 2012-11-26 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
04260636678998 P110008 000
04260148897832 P110008 000
04260148897849 P110008 000
04260148897856 P110008 000
04260148897863 P110008 000
04260148898341 P110008 000
04260148898457 P110008 000
04260148898464 P110008 000
04260148898471 P110008 000
04260148898488 P110008 000
04260148898495 P110008 000
04260148897825 P110008 000
04260148897801 P110008 000
04260148890116 P110008 000
04260148890123 P110008 000
04260148890130 P110008 000
04260148890147 P110008 000
04260148897740 P110008 000
04260148897757 P110008 000
04260148897764 P110008 000
04260148897771 P110008 000
04260148897788 P110008 000
04260148897795 P110008 000
04260148898501 P110008 000
04260148898518 P110008 000
04260148898525 P110008 000
04260148898839 P110008 000
04260148898846 P110008 000
04260148898853 P110008 000
04260148898860 P110008 000
04260148898877 P110008 000
04260148898884 P110008 000
04260148898891 P110008 000
04260148898907 P110008 000
04260148898914 P110008 000
04260148898990 P110008 000
04260148898822 P110008 000
04260148898815 P110008 000
04260148898808 P110008 000
04260148898532 P110008 000
04260148898549 P110008 000
04260148898594 P110008 000
04260148898600 P110008 000
04260148898709 P110008 000
04260148898716 P110008 000
04260148898723 P110008 000
04260148898730 P110008 000
04260148898747 P110008 000
04260148899003 P110008 000
04260148898358 P110008 008

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.